16 research outputs found

    Prospective memory in non-psychotic first-degree relatives of patients with schizophrenia

    Get PDF
    Although a number of studies have found prospective memory (PM) impairment in patients with schizophrenia, very little is known about the PM performance in non-psychotic relatives of these patients. The current study aimed to explore the PM performance in non-psychotic first-degree relatives of these patients. Two groups of participants (26 non-psychotic first-degree relatives of schizophrenia patients and 26 healthy comparison participants) were administered three PM tasks (time-, event-, and activity-based) and a set of neurocognitive tests. Results showed that the relatives performed significantly worse than the comparisons on most indices of the PM tasks, with a similar pattern of impairment found in other neurocognitive measures. Together with findings from previous studies, results of the current study suggest that PM may be a potential endophenotype for schizophrenia. (C) 2009 Elsevier Ireland Ltd. All rights reserved.</p

    Examination of postconcussion-like symptoms in healthy university students: Relationships to subjective and objective neuropsychological function performance

    No full text
    This study examined postconcussion-like symptoms in a group of university students and explored their relationships to neuropsychological function performance. A sample of 124 students was recruited. All of the participants received the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and completed a comprehensive set of neuropsychological tests. They reported a relatively high base rate of postconcussion-like symptoms. The most frequently endorsed items were "fatigue" (76.9%), "longer time to think" (60.3%), "poor concentration" (58.7%), "sleep disturbance" (50.4%), and "frustration" (46.3%). There were no significant differences between low symptom reporters and high symptom reporters, except for self-reported dysexecutive problems. A comparison of the healthy high symptom reporters and a convenient sample of traumatic brain injury patients revealed that the patients performed significantly worse on neuropsychological functions than the high symptom reporters, despite non-significant differences between symptom endorsement. Our findings demonstrate that: (a) the base rate of postconcussion-like symptoms in a group of healthy university students is relatively high and (b) postconcussion symptom (PCS) is not related to neuropsychological functions in normal people.This study examined postconcussion-like symptoms in a group of university students and explored their relationships to neuropsychological function performance. A sample of 124 students was recruited. All of the participants received the Rivermead Post-Concussion Symptoms Questionnaire (RPQ) and completed a comprehensive set of neuropsychological tests. They reported a relatively high base rate of postconcussion-like symptoms. The most frequently endorsed items were "fatigue" (76.9%), "longer time to think" (60.3%), "poor concentration" (58.7%), "sleep disturbance" (50.4%), and "frustration" (46.3%). There were no significant differences between low symptom reporters and high symptom reporters, except for self-reported dysexecutive problems. A comparison of the healthy high symptom reporters and a convenient sample of traumatic brain injury patients revealed that the patients performed significantly worse on neuropsychological functions than the high symptom reporters, despite non-significant differences between symptom endorsement. Our findings demonstrate that: (a) the base rate of postconcussion-like symptoms in a group of healthy university students is relatively high and (b) postconcussion symptom (PCS) is not related to neuropsychological functions in normal people. (c) 2006 National Academy of Neuropsychology. Published by Elsevier Ltd. All rights reserved

    The development of a Chinese equivalence version of Letter-Number Span Test

    No full text
    The present study aimed to develop a Chinese equivalence version of the Letter Number (LN) Span Test and to explore the preliminary construct and discriminative validity of the developed version among a group of healthy Chinese volunteers and patients with stroke. A group of 165 (73 men and 92 women) healthy participants were recruited for the validation study most of them were undergraduates or postgraduates. Moreover, a comparison was made between nine patients with stroke and the healthy controls. For the healthy sample, the Chinese version correlated significantly with the English version in total number of correct span (r = .6, p <.00001) and the longest span (r = .5, p <.00005). The Chinese version of LN Span Test was also found to be significantly associated with memory-loaded tests but not other tests. A series of ANCOVAs controlling for age, education, and IQ indicated that stroke patients performed significantly worse than the healthy controls in LN Span total number of correct responses (p <.04), immediate recall (p <.0005), and delayed recall (p <.0005) of WMS-R, SART total number of correct response (p <.0005), PASAT dyads correct response (p <.0 1). The preliminary findings suggest that the Chinese version of the LN Span Test shows impressive preliminary validity among a group of healthy volunteers and an impressive clinical discriminative validity among a group of stroke cases.The present study aimed to develop a Chinese equivalence version of the Letter Number (LN) Span Test and to explore the preliminary construct and discriminative validity of the developed version among a group of healthy Chinese volunteers and patients with stroke. A group of 165 (73 men and 92 women) healthy participants were recruited for the validation study most of them were undergraduates or postgraduates. Moreover, a comparison was made between nine patients with stroke and the healthy controls. For the healthy sample, the Chinese version correlated significantly with the English version in total number of correct span (r = .6, p <.00001) and the longest span (r = .5, p <.00005). The Chinese version of LN Span Test was also found to be significantly associated with memory-loaded tests but not other tests. A series of ANCOVAs controlling for age, education, and IQ indicated that stroke patients performed significantly worse than the healthy controls in LN Span total number of correct responses (p <.04), immediate recall (p <.0005), and delayed recall (p <.0005) of WMS-R, SART total number of correct response (p <.0005), PASAT dyads correct response (p <.0 1). The preliminary findings suggest that the Chinese version of the LN Span Test shows impressive preliminary validity among a group of healthy volunteers and an impressive clinical discriminative validity among a group of stroke cases

    Exploratory study on the base-rate of paranoid ideation in a non-clinical Chinese sample

    No full text
    Recent findings from several large-scale community surveys suggest that delusions tend to occur in non-clinical samples as a continuous phenotype rather than as an all-or-none phenomenon. However, the majority of studies on the prevalence of delusions and paranoid ideation are limited to Western samples. The present study aims to examine the phenomenon and base-rate of paranoid ideation in a Chinese non-clinical sample. A total of 4951 undergraduates (65.9% male) completed a checklist for paranoid ideation and the Schizotypal Personality Questionnaire (SPQ). Participants were classified into individuals with and without schizotypal personality disorder (SPD) features based on the SPQ. For the frequency subscale, 2.1-18.2% of the participants without SPD features experienced certain types of paranoid ideation at least once a week during the survey. The prevalence rate even elevated to a higher proportion in conviction and distress dimensions. For the conviction subscale, 93-53.5% of the participants somewhat believed of the ideations. For the distress subscale, 14.7-31.3% of the participants felt somewhat distressing in the experienced paranoid ideation. Participants with SPD features reported significantly higher prevalence in most items across these three dimensions. Findings indicate a high base-rate of attenuated forms of psychotic-like symptoms in a non-clinical Chinese sample, and provide further evidence for the continuity of psychotic phenomenon in non-clinical samples. (C) 2009 Elsevier Ireland Ltd. All rights reserved

    Sustained Attention Deficit Along the Psychosis Proneness Continuum A Study on the Sustained Attention to Response Task (SART)

    No full text
    Background: Sustained attention deficits have been associated with schizophrenia. However, these findings were limited to patients with schizophrenia and cannot be generalized to a wider nonclinical sample with schizotypal personality features

    Meta-analysis of prospective memory in schizophrenia: Nature, extent, and correlates

    No full text
    Prospective memory (PM) is the ability to remember to carry out an intended action in the future and it is an important function for everyday living. Studies have found that the neural basis of PM is located mainly in the prefrontal lobes (particularly in Brodmann Area 10) and patients with schizophrenia have functional deficits in this area. The present study provided a meta-analytic review of PM performances in patients with schizophrenia in 11 studies. A total of 485 patients with schizophrenia and 409 controls were included. Results showed that patients with schizophrenia exhibited impairments in all time- (d = -1.33), event- (d = -0.827). and activity-based (d = -0.729) PM, with time-based PM more impaired than event-based PM. In addition, PM was found to be significantly correlated with negative symptoms (r = -0.18), general psychopathology (r = -0.168), medication dosage (r = -0.119), duration of illness (r = -0.131), age (r = -0.23), education (r = 0.249), IQ (r = 0.439) and premorbid IQ (r = 0.356). It has theoretical and clinical implications. Theoretically, the results indicate time-based PM involves more initiation than event-based PM. Clinically, the results indicate patients on high dose of antipsychotic medication and with long duration of illness need special attention from care givers for PM problems. (C) 2009 Elsevier B.V. All rights reserved.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270758700009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=8e1609b174ce4e31116a60747a720701PsychiatrySCI(E)SSCI33REVIEW1-364-7011

    Exploratory study on the base-rate of paranoid ideation in a non-clinical Chinese sample

    No full text
    Recent findings from several large-scale community surveys suggest that delusions tend to occur in non-clinical samples as a continuous phenotype rather than as an all-or-none phenomenon. However, the majority of studies on the prevalence of delusions and paranoid ideation are limited to Western samples. The present study aims to examine the phenomenon and base-rate of paranoid ideation in a Chinese non-clinical sample. A total of 4951 undergraduates (65.9% male) completed a checklist for paranoid ideation and the Schizotypal Personality Questionnaire (SPQ). Participants were classified into individuals with and without schizotypal personality disorder (SPD) features based on the SPQ. For the frequency subscale, 2.1-18.2% of the participants without SPD features experienced certain types of paranoid ideation at least once a week during the survey. The prevalence rate even elevated to a higher proportion in conviction and distress dimensions. For the conviction subscale, 93-53.5% of the participants somewhat believed of the ideations. For the distress subscale, 14.7-31.3% of the participants felt somewhat distressing in the experienced paranoid ideation. Participants with SPD features reported significantly higher prevalence in most items across these three dimensions. Findings indicate a high base-rate of attenuated forms of psychotic-like symptoms in a non-clinical Chinese sample, and provide further evidence for the continuity of psychotic phenomenon in non-clinical samples. (C) 2009 Elsevier Ireland Ltd. All rights reserved.</p

    24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled Trial

    No full text
    <div><p>Objectives</p><p>The optimal treatment of hepatitis C virus (HCV) genotype 6 is unclear owing to its limited geographic distribution. Because of a high predictive value of rapid virological response (RVR) for sustained virological response (SVR), we conducted an open-label randomized controlled trial to compare 24- and 48-week peginterferon/ribavirin combination therapy for patients with HCV genotype 6 in Southern China who achieved an RVR.</p><p>Methods and Findings</p><p>Treatment-naive, non-cirrhotic patients with chronic hepatitis C genotype 6 were treated with pegylated interferon α-2a (180 μg/week) and ribavirin (800–1,200 mg, according to weight) for 4 weeks. Patients who achieved an RVR, which was defined as HCV RNA negativity at week 4 (<50 IU), were randomized to receive either an additional 20 or 44 weeks of treatment (24- and 48-week treatment groups, respectively). The primary outcome measure was SVR. From January 2011 to June 2014, 152(152/210, 72.4%) patients with HCV genotype 6a and RVR were randomized 1:1 to the 24- or 48-week treatment group. The SVR rates in the 24- and 48-week groups in the intention-to-treat analysis were 90.8% (69/76) and 88.2% (67/76), respectively; those in the per-protocol analysis were 95.7% (67/70) and 97.0% (64/66), respectively. More patients in the 48-week group had anemia (46.1% vs. 28.9%, <i>P</i> = 0.03), but other adverse events were comparable between the groups. The limitation of the present study was that only patients from Southern China were enrolled which may inhibit the extensive application of the findings.</p><p>Conclusion</p><p>Twenty-four weeks of peginterferon/ribavirin combination therapy was non-inferior to 48 weeks in patients with HCV genotype 6a in Southern China who achieved an RVR.</p><p>Trial Registration</p><p>ClinicalTrials.gov <a href="https://clinicaltrials.gov/ct2/show/NCT01263860" target="_blank">NCT01263860</a></p></div
    corecore